Compared to the full MOR agonist, buprenorphine has a ceiling effect on the MOR, providing less euphoric feelings and having less risk of respiratory depression; thus, it is safer than methadone and adequate to alleviate opioid withdrawal symptoms [59]. The gene discussed is OPRM1; the disease is Respiratory insufficiency due to muscle weakness.